These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 31109659

  • 1. Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer.
    Chapman BV, Swanick CW, Ning MS, Allen PK, Soliman PT, Westin SN, Pardeshi V, Broaddus RR, Lu KH, Jhingran A, Eifel PJ, Klopp AH.
    Gynecol Oncol; 2019 Jul; 154(1):22-28. PubMed ID: 31109659
    [Abstract] [Full Text] [Related]

  • 2. Postoperative external beam radiation therapy and concurrent cisplatin followed by carboplatin/paclitaxel for stage III (FIGO 2009) endometrial cancer.
    Milgrom SA, Kollmeier MA, Abu-Rustum NR, Tew WP, Sonoda Y, Barakat RR, Alektiar KM.
    Gynecol Oncol; 2013 Sep; 130(3):436-40. PubMed ID: 23800696
    [Abstract] [Full Text] [Related]

  • 3. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
    de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, Ottevanger PB, Ledermann JA, Khaw P, Colombo A, Fyles A, Baron MH, Jürgenliemk-Schulz IM, Kitchener HC, Nijman HW, Wilson G, Brooks S, Carinelli S, Provencher D, Hanzen C, Lutgens LCHW, Smit VTHBM, Singh N, Do V, D'Amico R, Nout RA, Feeney A, Verhoeven-Adema KW, Putter H, Creutzberg CL, PORTEC study group.
    Lancet Oncol; 2018 Mar; 19(3):295-309. PubMed ID: 29449189
    [Abstract] [Full Text] [Related]

  • 4. A multi-institutional analysis of sequential versus 'sandwich' adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma.
    Onal C, Sari SY, Yildirim BA, Yavas G, Gultekin M, Guler OC, Akyurek S, Yildiz F.
    J Gynecol Oncol; 2019 May; 30(3):e28. PubMed ID: 30887753
    [Abstract] [Full Text] [Related]

  • 5. Role of adjuvant therapy in stage IIIC2 endometrial cancer.
    Bogani G, Cappuccio S, Casarin J, Narasimhulu DMM, Cilby WA, Glaser GE, Weaver AL, McGree ME, Keeney GL, Weroha J, Petersen IA, Mariani A.
    Int J Gynecol Cancer; 2020 Aug; 30(8):1169-1176. PubMed ID: 32646864
    [Abstract] [Full Text] [Related]

  • 6. Node-positive adenocarcinoma of the endometrium: outcome and patterns of recurrence with and without external beam irradiation.
    Klopp AH, Jhingran A, Ramondetta L, Lu K, Gershenson DM, Eifel PJ.
    Gynecol Oncol; 2009 Oct; 115(1):6-11. PubMed ID: 19632709
    [Abstract] [Full Text] [Related]

  • 7. Defining the survival benefit of adjuvant pelvic radiotherapy and chemotherapy versus chemotherapy alone in stages III-IVA endometrial carcinoma.
    Xiang M, English DP, Kidd EA.
    Gynecol Oncol; 2019 Sep; 154(3):487-494. PubMed ID: 31257010
    [Abstract] [Full Text] [Related]

  • 8. Sequential versus "sandwich" sequencing of adjuvant chemoradiation for the treatment of stage III uterine endometrioid adenocarcinoma.
    Lu SM, Chang-Halpenny C, Hwang-Graziano J.
    Gynecol Oncol; 2015 Apr; 137(1):28-33. PubMed ID: 25666606
    [Abstract] [Full Text] [Related]

  • 9. The importance of adjuvant chemotherapy and pelvic radiotherapy in high-risk early stage endometrial carcinoma.
    Jutzi L, Hoskins P, Lim P, Aquino-Parsons C, Tinker A, Kwon JS.
    Gynecol Oncol; 2013 Dec; 131(3):581-5. PubMed ID: 24055614
    [Abstract] [Full Text] [Related]

  • 10. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
    Sueoka K, Umayahara K, Abe A, Usami T, Yamamoto A, Nomura H, Matoda M, Okamoto S, Omatsu K, Kondo E, Kato K, Takeshima N.
    Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094
    [Abstract] [Full Text] [Related]

  • 11. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
    Ma SK, Zhang HT, Sun YC, Wu LY.
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
    [Abstract] [Full Text] [Related]

  • 12. Survival Outcomes Improved in Contemporary Cohort of Patients With Pelvic or Abdominal Recurrence After Treatment for Stage I/II Endometrial Carcinoma.
    Xu MJ, Chu C, Rubin S, Lin LL.
    Am J Clin Oncol; 2017 Dec; 40(6):598-604. PubMed ID: 26237194
    [Abstract] [Full Text] [Related]

  • 13. Adjuvant carboplatin, paclitaxel, and vaginal cuff brachytherapy for stage III endometrial cancer: analysis of outcomes and patterns of recurrence based on pathologic characteristics.
    Young MR, Higgins SA, Ratner E, Yu JB, Mani S, Silasi DA, Azodi M, Rutherford T, Schwartz PE, Damast S.
    Int J Gynecol Cancer; 2015 Mar; 25(3):431-9. PubMed ID: 25621409
    [Abstract] [Full Text] [Related]

  • 14. Benefit of combination chemotherapy and radiation stratified by grade of stage IIIC endometrial cancer.
    Binder PS, Kuroki LM, Zhao P, Cusworth S, Divine LM, Hagemann AR, McCourt CK, Thaker PH, Powell MA, Mutch DG, Massad LS.
    Gynecol Oncol; 2017 Nov; 147(2):309-314. PubMed ID: 28916118
    [Abstract] [Full Text] [Related]

  • 15. Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer.
    Kiess AP, Damast S, Makker V, Kollmeier MA, Gardner GJ, Aghajanian C, Abu-Rustum NR, Barakat RR, Alektiar KM.
    Gynecol Oncol; 2012 Nov; 127(2):321-5. PubMed ID: 22850412
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nodal metastasis in endometrial cancer.
    Willis G, Misas JE, Byrne W, Podczaski E.
    Eur J Gynaecol Oncol; 2011 Nov; 32(3):259-63. PubMed ID: 21797112
    [Abstract] [Full Text] [Related]

  • 18. Adjuvant Treatment after Surgery in Stage IIIA Endometrial Adenocarcinoma.
    Yoon MS, Huh SJ, Kim HJ, Kim YS, Kim YB, Kim JY, Lee JH, Kim HJ, Cha J, Kim JH, Kim J, Yoon WS, Choi JH, Chun M, Choi Y, Lee KK, Kim M, Jeong JU, Chang SK, Park W.
    Cancer Res Treat; 2016 Jul; 48(3):1074-83. PubMed ID: 26511800
    [Abstract] [Full Text] [Related]

  • 19. Impact of different adjuvant treatment approaches on survival in stage III endometrial cancer: A population-based study.
    van Weelden WJ, Reijnen C, Eggink FA, Boll D, Ottevanger PB, van den Berg HA, van der Aa MA, Pijnenborg JMA.
    Eur J Cancer; 2020 Jul; 133():104-111. PubMed ID: 32454416
    [Abstract] [Full Text] [Related]

  • 20. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N.
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.